• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Smith & Nephew Acquires Brainlab Orthopaedic Joint Reconstruction Business

Share:

March 18, 2019

The two companies enter into a strategic collaboration for future development of technology for digital surgery across a broad range of clinical areas

Brainlab, the global pioneer of software-driven medical technology, and Smith & Nephew, the global medical technology business, announce that Smith & Nephew has agreed to acquire the Brainlab orthopaedic joint reconstruction business.

The acquisition supports Smith & Nephew’s strategy to invest in best in class technologies that further its multi-asset digital surgery and robotic ecosystem. The acquisition and strategic collaboration allow both companies to accelerate research and development in the areas of digital surgery and augmented reality.

The Brainlab orthopaedic joint reconstruction business provides surgeons with digital workflow tools, from pre-operative planning to intraoperative navigation to postoperative evaluation and sharing. Used in over 40,000 orthopaedic cases1 each year at more than 500 accounts worldwide, the technology helps maximise precision and reproducibility and achieve desired outcomes for patients and surgeons. The transaction also includes certain intangible assets as well as the orthopaedic Brainlab salesforce, which will be integrated into the Smith & Nephew robotics commercial organisation, supporting the acceleration of this business.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Smith & Nephew and Brainlab will collaborate in developing applications in orthopaedic reconstruction and sports medicine, with opportunities to expand into other surgical specialties thereafter. The partnership offers Smith & Nephew access to a broad range of Brainlab technologies in cloud computing, tracking, augmented reality, robotics, AI, machine learning, image fusion, and anatomical segmentation. The combined competencies will result in a powerful digital ecosystem from which ground-breaking clinical solutions can emerge, bolstering Smith & Nephew’s technology base for robotics. Brainlab will benefit from deploying its digital surgery products to the ambulatory surgery market through the broad Smith & Nephew distribution network. By working together, the companies will provide an exciting upgrade path with more capabilities for both Brainlab and Smith & Nephew customers.

“Computer-assisted surgery is the foundation of any powerful robotic solution and sophisticated software will drive superior robotic applications,” said Stefan Vilsmeier, President and CEO, Brainlab. “I’m excited about co-inventing the future of digital surgery with our new partner, and expanding the reach of our technology to ambulatory surgery centers and their patients.”

“This partnership with Brainlab is a critical driver of our digital surgery and robotic ecosystem,” said Namal Nawana, CEO of Smith & Nephew. “Together we will drive the development and adoption of digital technologies to dramatically improve efficiency and outcomes in the OR.”

Date: March 18, 2019

Source: Smith & Nephew

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • 10 Best Life Sciences Stocks for This Year – Top Stocks – TheStreet Ratings10 Best Life Sciences Stocks for This Year – Top Stocks – TheStreet Ratings
  • Healthcare Can Save $16.3B Automating Administrative Transactions, Report FindsHealthcare Can Save $16.3B Automating Administrative Transactions, Report Finds
  • Microsoft Launches $40M, 5-Year AI for Health Initiative to Advance Health GloballyMicrosoft Launches $40M, 5-Year AI for Health Initiative to Advance Health Globally
  • AxoSim Enters into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets.AxoSim Enters into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets.
  • Ayala Pharmaceuticals Announces Closing of Merger with BiosightAyala Pharmaceuticals Announces Closing of Merger with Biosight
  • New Startup Ophelia Focused on Opioid Use Disorder Scores $2.7MNew Startup Ophelia Focused on Opioid Use Disorder Scores $2.7M
  • Core One Labs Signs Letter of Intent to Acquire Vocan BiotechnologiesCore One Labs Signs Letter of Intent to Acquire Vocan Biotechnologies
  • Arcus Biosciences up 84% on Rumored Gilead InterestArcus Biosciences up 84% on Rumored Gilead Interest

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications